Clinical drug trials show promise in halting progressive brain atrophy of MS patients

by Stuart Tomlinson, KATU News

Wed, September 12th 2018, 1:00 AM UTC

Dr. Vijayshree Yadav, associate professor of neurology at OHSU, left, with MS patient and clinical drug trial subject, David Smeltzer. (KATU)

{p}Smeltzer, who realized his dream of being a radio announcer after his diagnosis, says while there's always hope, he has dealt with the disease with acceptance -- and a sense humor. "I always have this attitude that if I can’t’ laugh at things then I give up,” he said. “And by the way, my brain is not shrinking..despite what you may have heard.” KATU){/p}

The brains of 255 patients, including twelve at OHSU, at 28 hospitals across the us were studied using advanced MRI imaging over a two-year period.

VIEW ALL PHOTOS

View All Photos

Dr. Vijayshree Yadav, associate professor of neurology at OHSU, left, with MS patient and clinical drug trial subject, David Smeltzer. (KATU)

Loading ...